Bowen C P, Whitney L R, Truwit J D, Durbin C G, Moore M M
Division of Surgical Oncology, University of Virginia Medical Center, Charlottesville 22908-0709, USA.
Am Surg. 2001 Jan;67(1):54-60.
Tracheostomy continues to be a standard procedure for the management of long-term ventilator-dependent patients. Traditionally the procedure has been performed by surgeons in the operating theater using an open technique. This routine practice has recently been challenged by the introduction of bedside percutaneous dilatational tracheostomy (PDT), which has been reported to be a cost-effective alternative. The purpose of this study is to evaluate and compare the safety, procedure time, cost, and utilization of percutaneous and surgical tracheostomies at a university hospital. A retrospective medical chart review was performed on all ventilator-dependent intensive care unit patients at the University of Virginia Medical Center undergoing tracheostomy during a 23-month period beginning December 26, 1996. Of the 213 patients identified for review, 74 and 139 patients received percutaneous and surgical tracheostomies, respectively. Of 74 percutaneous tracheostomies, 73 reviewed were performed by general surgeons, pulmonary physicians, or anesthesiologists in the intensive care unit; all open tracheostomies were performed by surgeons in the operating room, and one percutaneous procedure was performed in the operating room. Perioperative complications occurred in five of 74 patients (6.76%) during PDT; of these, three patients (4.1%) experienced major complications requiring emergent operative exploration of the neck. Three patients (2.2%) experienced perioperative complications during surgical tracheostomy. The mean procedure time was significantly shorter for the percutaneous procedure. Average charges per patient in an uncomplicated case including professional fees, inventory, bronchoscopy (if performed), and operating room charges were $1753.01 and $2604.00 for percutaneous and standard tracheostomies, respectively. These charges do not include the charges associated with surgical intervention after PDT complications. In contrast to previously published reports showing complications clustered during a physician's first 30 percutaneous cases, our study demonstrated no relationship between complication occurrence and physician experience. That is, no learning curve associated with performing PDT was evident. In addition there was no association seen between physician specialty and complication rate. PDT in the intensive care unit costs less than surgical tracheostomy performed in the operating room and can be performed in less time. Several other studies have recommended that bronchoscopy during PDT provides additional safety; however, in our series all three major complications took place during bronchoscopy-assisted percutaneous procedures. Our series suggests that PDT carries an appreciable risk of major complications. Careful patient selection and additional experience with the procedure may decrease complication rates to an acceptable level.
气管切开术仍然是长期依赖呼吸机患者管理的标准手术。传统上,该手术由外科医生在手术室采用开放技术进行。最近,床边经皮扩张气管切开术(PDT)的引入对这种常规做法提出了挑战,据报道它是一种具有成本效益的替代方法。本研究的目的是评估和比较一所大学医院中经皮和外科气管切开术的安全性、手术时间、成本及利用率。对弗吉尼亚大学医学中心在1996年12月26日开始的23个月期间接受气管切开术的所有依赖呼吸机的重症监护病房患者进行了回顾性病历审查。在确定进行审查的213例患者中,分别有74例和139例接受了经皮和外科气管切开术。在74例经皮气管切开术中,73例审查病例由普通外科医生、肺科医生或麻醉医生在重症监护病房进行;所有开放气管切开术均由外科医生在手术室进行,1例经皮手术在手术室进行。PDT期间,74例患者中有5例(6.76%)发生围手术期并发症;其中,3例患者(4.1%)出现严重并发症,需要紧急进行颈部手术探查。3例患者(2.2%)在外科气管切开术期间发生围手术期并发症。经皮手术的平均手术时间明显更短。在一个不复杂的病例中,每位患者的平均费用包括专业费用、耗材、支气管镜检查(如进行)和手术室费用,经皮气管切开术和标准气管切开术分别为1753.01美元和2604.00美元。这些费用不包括PDT并发症后手术干预的相关费用。与之前发表的报告显示并发症集中在医生最初的30例经皮病例期间不同,我们的研究表明并发症的发生与医生经验之间没有关系。也就是说,进行PDT不存在明显的学习曲线。此外,未发现医生专业与并发症发生率之间存在关联。重症监护病房中的PDT比在手术室进行的外科气管切开术成本更低,且可在更短时间内完成。其他几项研究建议在PDT期间进行支气管镜检查可提供额外的安全性;然而,在我们的系列病例中,所有3例严重并发症均发生在支气管镜辅助经皮手术期间。我们的系列病例表明,PDT存在明显的严重并发症风险。仔细选择患者并增加该手术的经验可能会将并发症发生率降低到可接受的水平。